HomeCompareHTECX vs JNJ

HTECX vs JNJ: Dividend Comparison 2026

HTECX yields 22.89% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HTECX wins by $67.0K in total portfolio value
10 years
HTECX
HTECX
● Live price
22.89%
Share price
$19.96
Annual div
$4.57
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$87.0K
Annual income
$9,068.56
Full HTECX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HTECX vs JNJ

📍 HTECX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTECXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTECX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTECX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTECX
Annual income on $10K today (after 15% tax)
$1,945.24/yr
After 10yr DRIP, annual income (after tax)
$7,708.28/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HTECX beats the other by $7,004.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTECX + JNJ for your $10,000?

HTECX: 50%JNJ: 50%
100% JNJ50/50100% HTECX
Portfolio after 10yr
$53.5K
Annual income
$4,948.17/yr
Blended yield
9.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HTECX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTECX buys
0
JNJ buys
0
No recent congressional trades found for HTECX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTECXJNJ
Forward yield22.89%3.36%
Annual dividend / share$4.57$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$87.0K$20.0K
Annual income after 10y$9,068.56$827.78
Total dividends collected$52.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HTECX vs JNJ ($10,000, DRIP)

YearHTECX PortfolioHTECX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,989$2,288.52$10,676$355.77+$2.3KHTECX
2$16,676$2,777.99$11,407$389.39+$5.3KHTECX
3$21,176$3,333.27$12,198$426.53+$9.0KHTECX
4$26,615$3,955.96$13,056$467.62+$13.6KHTECX
5$33,124$4,646.63$13,987$513.12+$19.1KHTECX
6$40,848$5,404.82$14,998$563.56+$25.9KHTECX
7$49,936$6,229.02$16,098$619.52+$33.8KHTECX
8$60,548$7,116.76$17,295$681.69+$43.3KHTECX
9$72,851$8,064.67$18,599$750.82+$54.3KHTECX
10$87,020$9,068.56$20,022$827.78+$67.0KHTECX

HTECX vs JNJ: Complete Analysis 2026

HTECXStock

The fund invests primarily in companies whose securities are listed on U.S. national securities exchanges, including through American Depositary Receipts (“ADRs”), which are U.S. dollar-denominated securities of foreign issuers listed on U.S. national securities exchanges. Under normal circumstances, it invests at least 80% of its net assets in securities of companies that are principally engaged in the research, design, development, manufacturing, or distributing of products or services in the technology industry.

Full HTECX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HTECX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTECX vs SCHDHTECX vs JEPIHTECX vs OHTECX vs KOHTECX vs MAINHTECX vs ABBVHTECX vs MRKHTECX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.